Full text
| |
| Author(s): |
Rafael Fonseca Pereira
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | São Carlos. |
| Institution: | Universidade de São Paulo (USP). Instituto de Química de São Carlos (IQSC/BT) |
| Defense date: | 2011-08-02 |
| Examining board members: |
Antonio Carlos Bender Burtoloso;
Kleber Thiago de Oliveira
|
| Advisor: | Antonio Carlos Bender Burtoloso |
| Abstract | |
Chagas\'s disease is an endemic infection caused by the protozoan Trypanosoma cruzi, affecting near 15 milion of people in Latin America. In a search of an economical and efficient alternative for the treatment of this disease, Kiushi and colleagues isolated Komaroviquinone from the plant Darcocephalum komarovi. After in vitro studies of human cells (infected with trypomastigotes of Trypanosoma cruzi), komaroviquinone proved to be 15 to 300 times more efficient than the currently available prescriptions. Even with this encouraging result, little has been reported on the synthesis of komaroviquinone, and only four synthetic routes are described in the literature (two being enantioselective). Based on this fact, the present work deals with the study of a new strategy to synthesize komaroviquinone quickly and effectively, employing an epoxide ring-opening approach with aryl-magnesium and aril-lithium compounds as the key step. Using this strategy, komaroviquinone may be synthesized in 9 steps, starting from commercially starting materials. It should be noted that this strategy enables the synthesis of other natural products such as brussonol, which showed moderate cytotoxicity on insect-derived Spodoptera frugiperda pupal ovarian cells (Sf9), mammalian Chinese hamster ovary cell (CHO), and P388 murine leukemia cells. Some promising results were already obtained as the preparation one pote of ketone with yield in range of 54-65 % and the preptaration of the corresponding epoxide with 89 % yield. Besides this, the epoxide ring-opening approach could be applied with some aromatic model compounds (commercially available) with 53 % and 62 % yield, depending on the Grignard reagents employed. However, in order to prepare komaroviquinone, it is still necessary to optimize the reaction conditions so that the real aromatic derivatives (precursors of komaroviquinone and brussonol) may be used. (AU) | |
| FAPESP's process: | 09/03726-7 - Studies Towards the Synthesis of the Potent Tripanocidal (±)-Komaroviquinona |
| Grantee: | Rafael Fonseca Pereira |
| Support Opportunities: | Scholarships in Brazil - Master |